Correlation Between MERCK Kommanditgesells and MGC Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MERCK Kommanditgesells and MGC Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MERCK Kommanditgesells and MGC Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MERCK Kommanditgesellschaft auf and MGC Pharmaceuticals, you can compare the effects of market volatilities on MERCK Kommanditgesells and MGC Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MERCK Kommanditgesells with a short position of MGC Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MERCK Kommanditgesells and MGC Pharmaceuticals.

Diversification Opportunities for MERCK Kommanditgesells and MGC Pharmaceuticals

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between MERCK and MGC is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding MERCK Kommanditgesellschaft au and MGC Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MGC Pharmaceuticals and MERCK Kommanditgesells is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MERCK Kommanditgesellschaft auf are associated (or correlated) with MGC Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MGC Pharmaceuticals has no effect on the direction of MERCK Kommanditgesells i.e., MERCK Kommanditgesells and MGC Pharmaceuticals go up and down completely randomly.

Pair Corralation between MERCK Kommanditgesells and MGC Pharmaceuticals

Assuming the 90 days horizon MERCK Kommanditgesellschaft auf is expected to generate 0.51 times more return on investment than MGC Pharmaceuticals. However, MERCK Kommanditgesellschaft auf is 1.94 times less risky than MGC Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. MGC Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  17,040  in MERCK Kommanditgesellschaft auf on August 26, 2024 and sell it today you would lose (2,050) from holding MERCK Kommanditgesellschaft auf or give up 12.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy62.1%
ValuesDaily Returns

MERCK Kommanditgesellschaft au  vs.  MGC Pharmaceuticals

 Performance 
       Timeline  
MERCK Kommanditgesells 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MERCK Kommanditgesellschaft auf has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
MGC Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MGC Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, MGC Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

MERCK Kommanditgesells and MGC Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MERCK Kommanditgesells and MGC Pharmaceuticals

The main advantage of trading using opposite MERCK Kommanditgesells and MGC Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MERCK Kommanditgesells position performs unexpectedly, MGC Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGC Pharmaceuticals will offset losses from the drop in MGC Pharmaceuticals' long position.
The idea behind MERCK Kommanditgesellschaft auf and MGC Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities